itamar raz, md: impact of dapagliflozin on fast decline in egfr
Published 4 years ago • 592 plays • Length 11:26Download video MP4
Download video MP3
Similar videos
-
8:35
silvio inzucchi, md: implications of initial egfr response to empagliflozin
-
0:30
dapagliflozin can reduce gfr but .. #shorts #dapagliflozin
-
5:41
kieran docherty, mbchb: impact of t2d background therapy on dapagliflozin benefit
-
2:03
dapagliflozin clinically and cost effective in patients with chronic kidney disease dapa ckd trial
-
6:30
easd 2019 : declare-timi 58 - prof itamar raz
-
0:55
further research studies of dapagliflozin
-
14:44
highlight on dapagliflozin in patients with chronic kidney disease.prof. amr el-husseini,24 sep 2020
-
0:47
is dapagliflozin safe?
-
3:57
hfa 23: dapa-resist: dapagliflozin vs metolazone in patients with hf and diuretic resistance
-
9:22
dr. scott solomon: dapagliflozin benefits patients with heart failure and kidney disease
-
0:48
sglt2 inhibitors' kidney benefits across proteinuria degrees
-
35:40
efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease
-
2:41
fda approves empagliflozin for reducing kidney disease progression in ckd patients
-
3:50
dr. mcmurray discusses the dapa-hf trial of dapagliflozin in systolic heart failure
-
1:36
dapagliflozin (farziga) slows kidney function loss in iga nephropathy | farxiga and kidney disease
-
4:45
cost-effectiveness of dapagliflozin for non-diabetic chronic kidney disease
-
0:42
who is dapagliflozin for?
-
3:36
dapagliflozin
-
1:11
meet nephrologist aldo peixoto, md